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ABSTRACT 
 
This paper presents the results of bioinformatic analysis of five molecular genetic markers of 947 
women with uterine hyperplasia and 988 women of the control group. We found that the genetic variation ТТ 
rs7759938 in women of the Central region of Russia is associated with an increased risk of hyperplastic 
processes of the uterus (OR=1.35), and the protective value has the combination as follows: C rs7759938 with 
C rs2252673 (ОR=0.72), C rs7759938 with C rs4374421 and С rs466639 (ОR=0.68), СТ rs4374421 with СТ 
rs466639 (ОR=0.77), T rs7579411 with Т rs4374421 (ОR=0.78). 
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INTRODUCTION 
 
Benign proliferative diseases of the female reproductive system such as the uterine fibroid, genital 
endometriosis, endometrial hyperplastic processes, based on the pathologic hyperplastic processes of endo- 
and myometrium tissues, occupy a leading place in the structure of the common gynecological morbidity [1]. 
 
According to the literature, uterine fibroid occurs in 20-35% of women of reproductive age, and after 
50 years its prevalence is up to 70% [2-4].  Adenomyosis is present in 19.5% of the female population of 
reproductive age [5].Endometriosis accounts for 15-50% of all gynecological diseases [6-8]. Hyperplastic 
processes of the uterus have a common pathogenesis and therefore often occur concomitantly. 27% of 
women with endometriosis have a concomitant uterine fibroid. In addition, upon the uterus hysterectomy this 
combined pathology occurs in 15 to 57% of tissue samples of women with fibroids [9]. 
 
Now it is known that polymorphisms of several genes are important in the formation of disposition to 
the development of hyperplastic processes of uterus. However, the results of studies on the role of candidate 
genes in the formation of hyperplastic processes of the uterus are controversial in different populations.  
 
MATERIALS AND METHODS 
 
We conducted the analysis of the results of observations in 1935 people: 947 women with uterine 
hyperplasia and 988 women of the control group. The samples of case and control groups included women of 
Russian nationality being natives of the Central Black Earth Region of the Russian Federation and having no 
family ties with each other. Clinical and instrumental examination of patients with hyperplastic processes of 
the uterus was performed by doctors of the gynecological department of the Perinatal Center of St. Joasaph 
Belgorod Regional Clinical Hospital. The control group included women without gynecological diseases. 
 
All patients with hyperplastic processes of the uterus and individuals of control group underwent 
typing of five molecular genetic markers: LIN28B g.105485647C>T (rs7759938), LHCGR c.606-2195C>T 
(rs7579411), LHCGR c.680+695C>T (rs4374421), INSR с.2267+90G>С (rs2252673), RXRG c.-130-837A>G 
(rs466639). 
 
As the material for the study we used 8-9 ml of venous blood taken from the cubital vein of a 
proband. A genomic DNA was isolated from peripheral blood by the method of standard phenol-chloroform 
extraction [10]. Analysis of the investigated loci was carried out by the method of polymerase chain reaction of 
DNA synthesis with the use of oligonucleotide primers and probes. 
 
Analysis of the role of combination of genes under study in the formation of hyperplastic processes of 
the uterus was performed by APSampler operating Markov chain Monte Carlo, and Bayesian nonparametric 
statistics. In performing multiple comparisons we used the Bonferroni correction (pcor) in order to minimize the 
errors of the first kind [11]. 
 
RESULTS 
 
We examined 947 women with uterine hyperplasia and 988 women of the control group. The main 
characteristics of the study groups are shown in Table 1. The control group is fully comparable to the sample of 
patients with hyperplastic processes of the uterus by age, ethnicity, place of birth and height-for-weight 
characteristics (p>0.05). 
 
Table 1: Characteristics of the subjects from the case and control groups. 
 
Characteristics Cases Controls 
Total 988 947 
Age, yrs 36.05±11.06* 35.2±7.5 
Weight, kg 64.8±1.9* 62.4±2.8 
Height, cm 164.8±4.1* 167.5±3.7 
 
Note: *p>0.05 
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Study of the frequency of alleles in the investigated polymorphic markers of genes showed (Table 2) 
that the empirical distribution of genotypes corresponds to theoretically expected distribution at Hardy-
Weinberg equilibrium (p> 0.05) for all studied loci in patients with hyperplastic processes of the uterus and in 
the control group.  
 
Table 2: Summary information about the studied polymorphisms. 
 
Polymorphism Studied 
groups 
Minor allele MAF (%) HWE 
χ
2
 p 
rs7759938 Case C 55.28 0.89 >0.05 
 Control C 54.43 0.97 >0.05 
rs7579411 Case C 28.35 0.40 >0.05 
 Control C 30.10 0.32 >0.05 
rs4374421 Case C 31.01 0.35 >0.05 
 Control C 31.49 0.43 >0.05 
rs2252673 Case C 79.49 0.40 >0.05 
 Control C 79.47 0.17 >0.05 
rs466639 Case T 11.08 0.19 >0.05 
 Control T 12.36 0.44 >0.05 
 
Notes: MAF, minor allele frequency; Hardy – Weinberg equilibrium. P values were calculated using the χ2 test. 
 
Using bioinformatic analysis we identified a genetic variation associated with an increased risk of 
hyperplastic processes of the uterus: TT rs7759938 (OR=1.35), and the following combinations have a 
protective value: C rs7759938 with C rs2252673 (ОR=0.72), C rs7759938 with C rs4374421 with С rs466639 
(ОR=0.68), СТ rs4374421 with СТ rs466639 (ОR=0.77), T rs7579411 with Т rs4374421 (ОR=0.78) (Table 3). 
 
Table 3: Concentration combinations of alleles/genotypes of genes considered in patients with hyperplastic processes of 
the uterus and the control group 
 
SNP 1 SNP 2 SNP 3 Carriage Fisher's 
p-value 
(Bonferroni 
correction, рcor) 
Odds ratio 
(95% CI) Case Control 
ТТ rs7759938 
 
C rs7759938 
 
C rs7759938 
 
T rs7579411 
 
СТ rs4374421 
 
 
C rs2252673 
 
C rs4374421 
 
T rs4374421 
 
СТ rs466639 
 
 
 
 
C rs466639 
 
55.61 
 
41.83 
 
20.81 
 
54.44 
 
37.75 
48.19 
 
49.95 
 
27.78 
 
60.55 
 
44.02 
0.0007 (0.002) 
 
0.0003 (0.0012) 
 
0.0004 (0.003) 
 
0.005 (0.03) 
 
0.004 (0.02) 
1.35 (1.12-1.61) 
 
0.72 (0.60-0.87) 
 
0.68 (0.55-0.85) 
 
0.78 (0.64-0.94) 
 
0.77 (0.64-0.93) 
 
 
DISCUSSION 
 
According to our findings, a genetic variant TT rs7759938 is a risk factor for hyperplastic processes of 
the uterus (OR=1.35). Pathogenic significance of LIN28B rs7759938 in the formation of hyperplastic processes 
of the uterus identified in our study is consistent with literature data on its medical and biological effects in the 
body. Thus, LIN28B plays a key role in processes such as proliferation, differentiation, embryogenesis, and 
skeletal myogenesis, and is associated with insulin sensitivity [12, 13]. These pathogenetic mechanisms are 
important in the formation of hyperplastic processes of the uterus. 
 
According to the literature, the T LIN28B allele is associated with menarche age (p=0.019) [14]. Large 
number of studies determined the involvement of LIN28B gene into the formation of ovarian cancer, prostate 
cancer, and colon cancer. It should be noted that overexpression of LIN28B is correlated with decreased 
patient survival rate and increased probability of metastasis growth [15]. 
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SUMMARY 
 
Based on the results of our study we may conclude that the ТТ LIN28B genotype is a risk factor for 
hyperplastic processes of the uterus (OR=1.35) in women of the Central region of Russia, while the following 
combinations serve as the protective factors of formation of hyperplastic processes of the uterus: C rs7759938 
with C rs2252673 (ОR=0.72), C rs7759938 with C rs4374421 and С rs466639 (ОR=0.68), СТ rs4374421 with СТ 
rs466639  (ОR=0.77), T rs7579411 with Т rs4374421 (ОR=0.78). 
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